Laboratory of Stem Cell Regulation, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Laboratory of Biomedical Innovation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
Eur J Immunol. 2020 Jan;50(1):110-118. doi: 10.1002/eji.201848061. Epub 2019 Nov 19.
Mast cells are generally classified into two phenotypically distinct populations: mucosal-type mast cells (MMCs) and connective tissue-type mast cells (CTMCs). However, the molecular basis determining the different characteristics of the mast cell subclasses still remains unclear. Unfortunately, the number of mast cells that can be obtained from tissues is limited, which makes it difficult to study the function of each mast cell subclass. Here, we report the generation and characterization of MMCs and CTMCs derived from mouse BM mast cells (BMMCs). We found that the expression of galanin receptor 3 was elevated in MMCs when compared to the expression in CTMCs. Moreover, intraperitoneal injection of a galanin antagonist reduced MMCs and inhibited the inflammation of dextran sodium sulfate-induced colitis in mice. Therefore, these results suggest that galanin promotes MMC differentiation in vivo, and provide important insights into the molecular mechanisms underlying the differentiation of mast cell subclasses.
黏膜型肥大细胞(MMC)和结缔组织型肥大细胞(CTMC)。然而,决定肥大细胞亚类不同特征的分子基础仍不清楚。不幸的是,从组织中获得的肥大细胞数量有限,这使得研究每个肥大细胞亚类的功能变得困难。在这里,我们报告了源自小鼠 BM 肥大细胞(BMMCs)的 MMC 和 CTMC 的产生和特征。我们发现,与 CTMC 相比,MMC 中甘丙肽受体 3 的表达升高。此外,腹腔内注射甘丙肽拮抗剂可减少 MMC 并抑制右旋糖酐硫酸钠诱导的小鼠结肠炎的炎症。因此,这些结果表明甘丙肽在体内促进 MMC 分化,并为肥大细胞亚类分化的分子机制提供了重要的见解。